Subgroup Analysis Stratified by Baseline Pancreatic β-cell Function in a Japanese Study of Dulaglutide in Patients with Type 2 Diabetes

類似資料

• The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes
  著者:: Inagaki, Nobuya, 等
  出版事項: (2016)
• Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen
  著者:: Onishi, Yukiko, 等
  出版事項: (2020)
• Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies
  著者:: Suzuki, Shuichi, 等
  出版事項: (2017)
• Effect of Once-Weekly Dulaglutide on Glucose Levels in Japanese Patients with Type 2 Diabetes: Findings from a Phase 4, Randomized Controlled Trial
  著者:: Inoue, Megumi, 等
  出版事項: (2019)
• Dulaglutide 1.5 mg as an add‐on option for patients uncontrolled on insulin: Subgroup analysis by age, duration of diabetes and baseline glycated haemoglobin concentration
  著者:: Pantalone, Kevin M., 等
  出版事項: (2018)